BIOVIE INC.

BIVI

BIOVIE INC.

BIVI

Insider Sentiment (TTM):

Last Purchase:2025-08-07Last Sale:2023-12-01Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:932,334Shares Outstanding:7,543,923Institutional Ownership Pct.:12.36%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	9	13	21	25	18	23	24	20	24	30	20	21
Grants Receivable Current	-	-	-	0	2	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	-	-	-	1	1	1	0	-	0	-	-	-
Grants Receivable	-	2	0	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets	-	2	1	-	-	-	-	0	0	0	0	2
Assets Current	14	17	22	26	21	24	25	20	24	31	21	23
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	-	0	0	0	0	0	0	0	0	0	1	1
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Assets	14	18	23	27	22	25	26	21	25	32	21	24
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	2	3	2	2	2	1	3	4	4	4	3
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Notes Payable Current	-	-	-	-	-	-	-	3	6	8	10	9
Embedded Derivative Fair Value Of Embedded Derivat…	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current	4	2	3	2	2	3	1	7	9	12	14	13
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	-	3
Liabilities	4	2	3	2	3	3	2	7	10	13	14	16
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	385	384	383	382	371	370	370	353	350	348	328	319
Retained Earnings Accumulated Deficit	-374	-369	-363	-357	-352	-349	-346	-339	-334	-329	-320	-312
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	10	16	19	25	19	22	24	14	16	19	7	8
Liabilities And Stockholders Equity	14	18	23	27	22	25	26	21	25	32	21	24
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	800	800	800	800	800	800	800	800	800	800	800	800
Common Stock Shares Issued	8	8	8	8	2	2	2	1	1	2	4	4
Shares Outstanding	8	8	8	8	2	2	2	1	1	6	4	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	1.28%	-14.74%	-26.92%	22.12%	20.35%	32.74%	18.52%	44.44%	5.93%	-	-	-
2025	-12.02%	-34.60%	-51.61%	-33.89%	-56.94%	-32.78%	-6.09%	-16.52%	-47.57%	5.45%	18.18%	6.06%
2024	-60.56%	-70.42%	-78.43%	-34.73%	-56.36%	-55.45%	-13.63%	-18.04%	-27.86%	138.33%	154.17%	58.33%
2023	-	-	-	-	-	-	-	-	-	-8.99%	3.17%	8.47%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.59	9.97	7.25	15.83	9.10	9.32	16.94	2.95	2.57	2.45	1.47	1.72
Quick Ratio	3.59	9.97	7.25	15.30	8.64	9.09	16.75	2.95	2.55	2.45	1.47	1.72
Working Capital	9.85M	15.19M	18.79M	24.39M	18.42M	21.17M	23.22M	13.31M	14.70M	18.06M	6.58M	9.55M
Leverage & Debt
Debt to Equity	0.39	0.12	0.17	0.08	0.13	0.13	0.07	0.51	0.63	0.68	1.87	2.15
Interest Coverage TTM	-1,626.93	-1,088.49	-1,013.71	-244.38	-54.30	-25.00	-17.20	-11.85	-11.12	-10.77	-11.06	-11.09
Debt Ratio	0.28	0.11	0.14	0.07	0.12	0.12	0.07	0.34	0.38	0.40	0.65	0.68
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-3.05	-2.64	-2.20	-3.54	-11.87	-10.26	-16.01	-41.34	-73.05	-82.98	-113.35	-137.65
Free Cash Flow Per Share TTM	-2.63	-2.72	-1.81	-3.54	-12.88	-9.41	-14.01	-30.24	-61.85	-78.63	-107.70	-117.66
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	25.83%	4.86%	-30.70%	-30.14%	-46.85%	-48.91%	-41.85%	-47.68%	-34.32%	-41.28%	4.93%	63.28%
EPS Growth (1Y)	-74.34%	-74.28%	-86.25%	-91.43%	-83.75%	-87.63%	-85.88%	-69.97%	-52.78%	363.01%	756.82%	1,109.87%
Valuation Metrics
P/E TTM	-0.64	-0.53	-0.53	-0.54	-0.78	-0.95	-1.25	-0.29	-0.55	-0.64	-1.11	-2.48
P/B TTM	1.37	0.68	0.48	0.40	0.72	0.83	1.31	0.55	1.17	1.25	6.42	16.59
Market Cap	14.06M	10.56M	9.19M	9.91M	13.67M	18.14M	31.43M	7.68M	18.12M	23.70M	48.10M	125.23M
Enterprise Value	5.08M	-2.54M	-11.35M	-15.07M	-3.88M	-5.01M	7.03M	-9.03M	-23.28K	1.34M	38.06M	116.33M
Calculated Values
Free Cash Flow TTM	-19.02M	-20.51M	-14.32M	-18.47M	-19.03M	-17.42M	-22.02M	-19.35M	-27.95M	-35.23M	-41.11M	-43.21M
Net Debt	-8.98M	-13.10M	-20.54M	-24.98M	-17.54M	-23.15M	-24.41M	-16.70M	-18.14M	-22.36M	-10.03M	-8.91M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-07Purchase

Owner: Do, Cuong V

Title: President & CEO

Shares: 5,000

Price/Share: -

Value: -

Shares Owned: 9,992

Relationship: Director,Officer

Ownership: Indirect

2024-03-04Purchase

Owner: Do, Cuong V

Title: President & CEO

Shares: 10,000

Price/Share: -

Value: -

Shares Owned: 435,854

Relationship: Director,Officer

Ownership: Indirect

2023-12-01Sale

Owner: Gorlin, Steve

Title: -

Shares: 75,680

Price/Share: $1.69

Value: $127,899.20

Shares Owned: 46,358

Relationship: Director

Ownership: Direct

2023-11-30Purchase

Owner: Do, Cuong V

Title: President & CEO

Shares: 10,000

Price/Share: $1.78

Value: $17,800.00

Shares Owned: 68,759

Relationship: Director,Officer

Ownership: Direct

2023-09-05Sale

Owner: Gorlin, Steve

Title: -

Shares: 8,560

Price/Share: $3.05

Value: $26,108.00

Shares Owned: 75,680

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-07	Do, Cuong V	Director,Officer	President & CEO	Indirect	Purchase	5,000	-	-	9,992	4
2024-03-04	Do, Cuong V	Director,Officer	President & CEO	Indirect	Purchase	10,000	-	-	435,854	4
2023-12-01	Gorlin, Steve	Director	-	Direct	Sale	75,680	1.69	$127,899.20	46,358	4
2023-11-30	Do, Cuong V	Director,Officer	President & CEO	Direct	Purchase	10,000	1.78	$17,800.00	68,759	4
2023-09-05	Gorlin, Steve	Director	-	Direct	Sale	8,560	3.05	$26,108.00	75,680	4
2023-08-22	Berman, Richard J	Director	-	Direct	Sale	10,805	3.50	$37,817.50	16,789	4
2023-06-07	Berman, Richard J	Director	-	Direct	Sale	5,984	5.81	$34,767.04	23,210	4
2023-03-28	Berman, Richard J	Director	-	Direct	Sale	7,613	8.52	$64,862.76	34,194	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

12.36%

Inst. Shares: 932,334

Shares Outstanding: 7,543,923

2025-12-31

13.69%

Inst. Shares: 1,084,382

Shares Outstanding: 7,920,795

2025-09-30

21.48%

Inst. Shares: 1,119,999

Shares Outstanding: 5,214,355

2025-06-30

74.25%

Inst. Shares: 1,096,988

Shares Outstanding: 1,477,372

2025-03-31

52.83%

Inst. Shares: 977,698

Shares Outstanding: 1,850,722

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	932,334	7,543,923	12.36%
2025-12-31	1,084,382	7,920,795	13.69%
2025-09-30	1,119,999	5,214,355	21.48%
2025-06-30	1,096,988	1,477,372	74.25%
2025-03-31	977,698	1,850,722	52.83%
2024-12-31	756,209	1,571,725	48.11%
2024-09-30	162,688	639,836	25.43%
2024-06-30	4,386,440	451,853	-
2024-03-31	6,316,452	4,480,108	140.99%
2023-12-31	1,756,424	3,817,077	46.01%
2023-09-30	1,687,004	3,672,490	45.94%
2023-06-30	1,844,906	3,248,349	56.80%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

BIOVIE INC. (BIVI) — SEC Financial Statements & Analysis

BIOVIE INC. (BIVI) is a pharmaceutical preparations company, incorporated in NV. BIOVIE INC. trades on Nasdaq as: BIVI, BIVIW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), BIOVIE INC. reported a Debt-to-Equity ratio of 0.39x, a Price-to-Book (P/B) ratio of 1.37x (TTM), at a market cap of $14.06M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.39x
P/B TTM: 1.37x
Market Cap: $14.06M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BIOVIE INC. in?

BIOVIE INC. (BIVI) operates in the Pharmaceutical Preparations industry.

What is BIVI's market cap?

BIOVIE INC. (BIVI) has a market capitalization of $14.06M as of 2026-06-30.

What exchange does BIVI trade on?

BIOVIE INC. (BIVI) trades on the Nasdaq.

Where is BIOVIE INC. incorporated?

BIOVIE INC. is incorporated in NV.

BIOVIE INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

BIOVIE INC. (BIVI) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

BIOVIE INC. (BIVI) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.